Related Experiment Video
Updated: Aug 23, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant
S K Bouchillon1, B M Johnson, D J Hoban
1Laboratories International for Microbiology Studies, 2122 Palmer Road, Schaumburg, IL 60173-3817, USA. sambouchillon@comcast.net
Abstract:
The PEARLS study prospectively monitored selected nosocomial pathogens from 38 centres in 13 European, three Middle Eastern countries and South Africa during 2001-2002. Extended spectrum beta-lactamase (ESBL) production rates among Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp. were 5.4% (142/2609), 18.2% (401/2,206) and 8.8% (204/2,328), respectively, for all study sites. The overall ESBL production rate for the combined Enterobacteriaceae was 10.5% (747/7,143), highest in Egypt, 38.5%, and Greece, 27.4%, and lowest in The Netherlands, 2.0%, and Germany, 2.6%. IEF, PCR and DNA sequencing determined 10.7% false positives among Enterobacter spp. when using NCCLS guidelines to screen for ESBL production. The prevalence of nosocomial methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium was 32.4% (294/908) and 8.7% (83/949), respectively. PEARLS provides baseline data against which prospective changes in resistant determinants and outcomes can be measured in this ongoing study.
Insights
The PEARLS study tracked nosocomial pathogens across Europe, the Middle East, and South Africa. It found significant rates of antimicrobial resistance, including extended-spectrum beta-lactamase production and MRSA.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Nosocomial pathogens pose a significant threat to patient safety worldwide.
- Antimicrobial resistance (AMR) is a growing global health concern, necessitating surveillance.
- Previous data on resistance patterns in specific regions were limited.
Purpose of the Study:
- To prospectively monitor selected nosocomial pathogens in multiple countries.
- To establish baseline data on the prevalence of key resistant determinants.
- To provide a foundation for future comparative studies on AMR trends.
Main Methods:
- Prospective surveillance of nosocomial pathogens across 38 centers in 16 countries.
- Laboratory identification and characterization of bacterial isolates, including ESBL production.
- Molecular techniques (IEF, PCR, DNA sequencing) to confirm resistance mechanisms and identify false positives.
Main Results:
- Overall extended-spectrum beta-lactamase (ESBL) production rates were 10.5% for Enterobacteriaceae, with significant geographic variation (e.g., Egypt 38.5%, The Netherlands 2.0%).
- Prevalence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) was 32.4% and vancomycin-resistant Enterococcus faecium (VRE) was 8.7%.
- A 10.7% false-positive rate was identified for ESBL screening in Enterobacter spp. using NCCLS guidelines.
Conclusions:
- The PEARLS study established crucial baseline data on antimicrobial resistance in nosocomial pathogens.
- Significant regional differences in resistance rates highlight the need for tailored infection control strategies.
- Ongoing monitoring is essential to track changes in resistance determinants and inform clinical practice.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA